Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase

This publication has 29 references indexed in Scilit:

• Development of vaccines against human parasitic diseases: tools, current status and perspectives
  Expert Opinion on Investigational Drugs, 2000
• The search for a vaccine against schistosomiasis - a difficult path hut an achievable goal
  Immunological Reviews, 1999
• Why Don't We Have a Schistosomiasis Vaccine?
  Parasitology Today, 1998
• T cell responses are governed by avidity and co‐stimulatory thresholds
  European Journal of Immunology, 1996
• Side Reaction During the Deprotection of Cys(Acm)-Containing Peptides with Iodine. Synthesis of Disulfide Fragments from Cathepsin D Structure
  Collection of Czechoslovak Chemical Communications, 1995
• Complete sequence of the Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase gene encoding a major surface antigen
  Molecular and Biochemical Parasitology, 1992
• The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase.
  The Journal of Experimental Medicine, 1989
• Production and characterization of monoclonal antibodies to anti-human chorionic somatomammotropin by immunization with two free synthetic peptides
  Molecular Immunology, 1985
• Effector and Regulatory Mechanisms in Immunity to Schistosomes: A Heuristic View
  Annual Review of Immunology, 1985
• Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. I. Evidence that the loss in susceptibility to immune damage undergone by developing schistosomula involves a change unrelated to the masking of parasite antigens by host molecules.
  The Journal of Experimental Medicine, 1980